Bullpen.News From Edwin Dorsey
Get Daily Recap Feedback

Thursday, November 5, 2026

Back to the front page

From X

@StableBread

Fajasy on X

From $3.83/share, you’re risking a $1.62 loss (-42.3%) on TOYO Co., Ltd $TOYO in my bear case for a $10.90 gain (+284.6%) in my bull case. I apply 2.0-4.0x EBITDA, well below First Solar $FSLR’s 6.7x, for the trade and governance risks. At the 3.0x midpoint, today’s $137.2M EV implies $TOYO earns just $45.7M/year, 29.2% of its TTM figure. How much of the $156.4M of TTM EBITDA lasts depends on Commerce, U.S. customs (CBP), and $TOYO’s Section 232 term sheet (its request for relief from the new 15% tariff on imported cells). Each case values $TOYO at the end of 2027 on that year’s EBITDA, since 2027 is the first full year under the new tariff and Commerce’s final determination is due ~May 13, 2027. I leave out the 45X tax credits, which $TOYO also leaves out of its forecasts, and the HJT cell plant it plans in Texas, which won’t produce before 2028. Each case adds today’s $26.4M of net cash to 2027 EBITDA times the multiple and divides by 42.7M shares. Bear Case ($2.21, -42.3%) The bear case assumes Commerce’s preliminary determination (its first ruling, due ~December 14) covers Ethiopian cells without the certification path $TOYO asked for, CBP keeps detaining shipments, and Commerce doesn’t approve $TOYO’s Section 232 term sheet. That means Ethiopia’s cells stop reaching U.S. buyers in 2027, which implies 2027 EBITDA of $34.0M, what $TOYO earned in Q2 2026 alone. I apply a 2.0x multiple, under a third of First Solar’s 6.7x, for a value of $2.21/share. Base Case ($6.38, +66.6%) The base case assumes Commerce lets cells made with non-Chinese wafers through by its May 2027 final determination, but CBP’s reviews and the inquiry keep Ethiopia’s U.S. sales below their H1 2026 pace until then. That implies 2027 EBITDA of $82.1M, the same as H1 2026 alone, or 52.5% of the TTM figure. I apply a 3.0x multiple, under half of First Solar’s 6.7x, for a value of $6.38/share. Bull Case ($14.73, +284.6%) The bull case assumes Commerce’s preliminary determination clears cells made with non-Chinese wafers, CBP releases $TOYO’s shipments, and Commerce approves its Section 232 term sheet, so Ethiopia’s cells reach U.S. buyers at the H2 2025-H1 2026 pace again. That implies 2027 EBITDA of $156.4M, equal to the TTM figure. I apply a 4.0x multiple, still well below First Solar’s 6.7x, for a value of $14.73/share after the warrants are exercised.
@DOMOCAPITAL 2 clicks

DOMO Capital Management, LLC on X

For those that missed the Gabelli conference yesterday, the $MNRO CFO had this to say when asked about why they went forward with the Ares financing (TLDR: They are selling the company soon): "We think that Ares is a great partner for us. It provides us a lot of flexibility to operate our business, both from a covenant standpoint, but also doing it with a partner who has experience in the auto aftermarket, and also provides a very sophisticated and tailored private credit solution for us. We had plenty of options as we looked to refinance the credit facility, including our more traditional bank lenders and various different private lenders, but ultimately Ares provided us with the best solution for what we felt were our needs. And our needs really were focused on creating a stable financing backdrop for us over our planning horizon, enabling us to not only execute our growth strategy, but providing flexibility for us to explore a wide range of the alternatives that we're currently evaluating. So we think that this credit facility accomplishes all of those things."

Investor Letters

All letters

VSH Earnings Review

Vishay reported record Q3 revenue of $979 million, up 24%, and guided Q4 to about $990 million as rising backlog and margins contrast with…

VSH $3.6B
Cestrian Capital Research 3 clicks

Research Note

Nine Mile Metals is the subject of a research note.

VMSXF $14M
Atrium Research - Equity Research 4 clicks

New Ideas From The Road

Aurelion Research increased healthcare exposure and sees opportunities in banking and defense, alongside research on Alcoa, Nike, ONON and…

MDA $4.2B
Aurelion Research 4 clicks

Site Centers (NYSE:SITC)

Site Centers' $3 per-share return-of-capital distribution and December delisting leave a discounted liquidation stub, with two properties…

SITC $192MCURB $3.6B
Real Assets, Real Value 4 clicks
SILC · long

Silicom LTD

Silicom (SILC) is pitched as inexpensive on its existing hardware business, with upside framed as a cheap call option.

SILC $183M
Value Investors Club 4 clicks

Namib Minerals: Research Flash

Namib Minerals accelerates Redwing’s restart, targeting first gold this month and a ramp from 338 ounces monthly to 835 ounces by Q2 2027.

NAMM $46M
Atrium Research - Equity Research 6 clicks

Stevanato down 30%. Yikes.

Stevanato fell 30% after forecasting low-single-digit 2027 growth as lower Nexa syringe volumes from a GLP-1 customer offset solid Q3…

STVN $3.6B
Best Anchor Stocks 3 clicks

Initiation Report

Nine Mile Metals is initiated under research coverage.

VMSXF $14M
Atrium Research - Equity Research 2 clicks

Publications we follow

Every publication on this site, hand-picked.

129 publications

Newsletters 109

YouTube 4

Blogs 15

Seeking Alpha 74 of 276

Nominate a publication

X accounts we follow

Every account on this site, hand-picked.

91 accounts
Nominate an account

Investor letters we follow

359 firms

Sectors

Ordered by how often our editor reaches for them.